Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.32 BRL | -6.86% |
|
+0.86% | -12.26% |
May. 08 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 15.25 times the sales for the current fiscal year, the company turns out to be overvalued.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Marine Port Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.26% | 1.19B | - | ||
+45.79% | 12.47B | B | ||
+29.26% | 6.82B | - | B+ | |
+0.40% | 2.33B | - | - | |
+6.81% | 1.75B | - | C+ | |
+49.30% | 1.33B | C+ | ||
-.--% | 1.02B | - | - | |
+16.60% | 1B | - | ||
+10.99% | 683M | - | B- | |
+26.67% | 648M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PORT3 Stock
- Ratings Wilson Sons S.A.